Pergolide Pulmonary Fibrosis Side Effect Reports
The following Pergolide Pulmonary Fibrosis side effect reports were submitted by healthcare professionals and consumers.
This information will help you understand how side effects, such as Pulmonary Fibrosis, can occur, and what you can do about them.
A side effect could appear soon after you start Pergolide or it might take time to develop.
|Blood Lactate Dehydrogenase Increased, Hyponatraemia, Interstitial Lung Disease, Pulmonary Fibrosis, Pulmonary Hypertension, Right Ventricular Failure, Subileus|
This Pulmonary Fibrosis side effect was reported by a health professional from FRANCE. A 83-year-old patient (weight:NA) experienced the following symptoms/conditions: parkinson's disease. The patient was prescribed Pergolide Mesylate (dosage: 2 Mg;qd;po), which was started on Jan 01, 2003. Concurrently used drugs:
This Pulmonary Fibrosis Pergolide Mesylate side effect was reported by a physician from on Jan 04, 2005. A male , 66 years of age, was diagnosed with
Pergolide Pulmonary Fibrosis Causes and Reviews
Pulmonary fibrosis is a condition in which the tissue deep in your lungs becomes scarred over time. This tissue gets thick and stiff. That makes it hard for you to catch your breath, and your blood may not get enough oxygen.
Causes of pulmonary fibrosis include environmental pollutants, some medicines, some connective tissue diseases, and interstitial lung disease. Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. In most cases, the cause cannot be found. This is called idiopathic pulmonary fibrosis.
- Shortness of breath
- A dry, hacking cough that doesn't get better
- Weight loss for no known reason
- Aching muscles and joints
- Clubbing, which is the widening and rounding of the tips of the fingers or toes
Your doctor may use your medical history, imaging tests, a biopsy, and lung function tests to diagnose pulmonary fibrosis. There is no cure. Treatments can help with symptoms and improve your quality of life. They include medicines, oxygen therapy, pulmonary rehabilitation, or a lung transplant.
NIH: National Heart, Lung, and Blood Institute
Pergolide Pulmonary Fibrosis ReviewsNo reviews submitted yet, check in later.